middle.news
How Will Invion Navigate $8.8M Loss Amid Clinical Breakthroughs?
1:02am on Saturday 30th of August, 2025 AEST
•
Healthcare
Read Story
How Will Invion Navigate $8.8M Loss Amid Clinical Breakthroughs?
1:02am on Saturday 30th of August, 2025 AEST
Key Points
Net loss increased 56.5% to $8.8 million for FY25
No revenue recorded, down 100% from prior year
Progress in Phase I/II trials for non-melanoma skin cancer and prostate cancer
Raised approximately $2 million via share placement and $980,000 through loyalty option entitlement
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Invion (ASX:IVX)
OPEN ARTICLE